Investors

Shareholder Services

Annual Reports
2018 Download
2017 Download
2016 Download
2015 Download
2014 Download
2013 Download
2012 Download
2011 Download
2010 Download


Top ten shareholders

as of 4/25/2019
Top 10 Shareholders Total Shares Owned Holding Percentage
Alvogen Emerging Markets Holdings Ltd. Representative: Divya C. Patel 151,100,000 62.15%
Fuji Pharma Co., Ltd. 4,913,220 2.02%
Xihao Lu 2,500,000 1.03%
JPMorgan Chase Bank N.A. Taipei Branch in custody for Vanguard Total International Stock Index Fund a series of Vanguard Star Funds 2,152,779 0.89%
Mercuries Life Insurance Co., Ltd. Representative: Xiangyu Chen 1,802,000 0.74%
VANGUARD EMERGING MARKETS STOCK INDEX FUND A SERIES OF VANGUARD INTERNATIONAL EQUITY INDEX FUNDS 1,239,000 0.51%
Numeric Emerging Markets Small Cap Core Offshore Fund Ltd. 821,000 0.34%
BNS Asia Limited 778,000 0.32%
Charles Lin 610,196 0.25%
Global Prime Partners Ltd 600,000 0.25%

Stakeholder Contact

Spokesperson  

Bjartur Shen  
Stratigies and Finance VP  
Tel: +886 2 2700 5908

Sales, Purchasing And CS Representative

電話:+886 2 2700 5908
Email: info@lotuspharm.com

Acting Spokesperson

Angela Luan
Corporate Finance and Regional Investor Relations Director
Tel: +886 2 2700 5908
Email: investor@lotuspharm.com

Transfer Agent

Yuanta Securities
Stock Affairs
Add: B1, No.210, Sec. 3, ChengDe Rd., 
Taipei City,
Taiwan
Tel: +886 2 2586 5859

Adverse Reaction Contact

Tel: +886 2 2700 5908 Ext: 1338/1339
Email: lotus.pv@alvogen.com